we do target cells specifically, in animals and Petri dish. We still are yet to prove it works in humans. That’s the rerate we await, and it will be quite interesting to watch as others learn about our platform as well.
the tricky part is working out when we will show that efficacy. We have the potential for eyesight to start improving in all the dosed candidates ie ph I and at about the 8 month mark there is a possibility that these individuals will report lack of deterioration in their vision. That’s a game changer, and could be sometime late this quarter giving the dosing dates.
we do target cells specifically, in animals and Petri dish. We...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.020(1.74%) |
Mkt cap ! $659.0M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.13 | $187.3K | 162.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5698 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 938 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |